Skip to main content
Signal8

TAKANASHI KEN

SEC insider (Form 3/4/5 filer). CIK 0001657768. Director at Wave Life Sciences, Inc. (WVE). 5 reported Form 4/5 transactions since Sep 2024; latest on Oct 5, 2026. Located in KAGOSHIMA.

Companies TAKANASHI KEN has filed insider reports for

  • Wave Life Sciences, Inc. (WVE): Director
TAKANASHI KEN profile photo

TAKANASHI KEN

CIK: 0001657768

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (40.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Wave Life Sciences, Inc. logo
WVE

Wave Life Sciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Wave Life Sciences, Inc. logo
    WVE

    Wave Life Sciences, Inc.

    Oct 5, 2026
    Award
    Direct
    10.7K shares-
  • Wave Life Sciences, Inc. logo
    WVE

    Wave Life Sciences, Inc.

    Aug 11, 2026
    Sale
    Direct
    3.9K shares at avg. $6.01$23K
  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Mar 23, 2026
    Conversion
    Indirect
    3.9M shares-
  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Aug 11, 2025
    Award
    Direct
    12.7K shares-
  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Aug 5, 2025
    Sale
    Direct
    4.9K shares at avg. $8.75$43K

1-5 of 5